Journal of Drugs in Dermatology - FDA approves Olux-E Foam
March 1, 2007 -- Stiefel Laboratories recently announced that the FDA has approved Olux-E[TM] (clobetasol propionate) Foam, 0.05% for the treatment of psoriasis and...
Skin & Allergy News - YAZ, Olux, Humira, Cymbalta
May 1, 2007 -- YAZ (drospirenone and ethinyl estradiol tablets, Berlex Laboratories Inc.) The Food and Drug Administration approved a new indication for YAZ...
Pediatric News - YAZ, Olux-E Foam, 0.05%
March 1, 2007 -- YAZ (drospirenone and ethinyl estradiol tablets, Berlex Laboratories Inc.) The Food and Drug Administration approved a new indication for YAZ...
Business Wire - Stiefel Laboratories Receives FDA Approval of Olux-E Foam, 0.05% for Treatment of Psoriasis and Eczema
January 23, 2007 -- -- Company's Second Product in Emollient-Based Foam Delivery Vehicle -- CORAL GABLES, Fla. -- Stiefel Laboratories, Inc., the world's largest...
Biotech Business - CONNETICS GETS FDA APPROVALTO EXPAND OLUX'S USE FOR PSORIASIS.
February 1, 2003 -- Connetics Corporation (Nasdaq: CNCT), Palo Alto, Calif., a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Connetics Second Quarter Revenues Increase 19 Percent; OLUX, Soriatane and Evoclin Achieve All-Time Quarterly Prescription Highs; Company Increases Full-Year...
August 2, 2005 -- PALO ALTO, Calif. -- Connetics Corporation (NASDAQ:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Dermatology Nursing - OLUX®, treats mild-to-moderate nonscalp psoriasis
August 1, 2002 -- Connetics Corporation, a specialty pharmaceutical company focused exclusively on the development and commercialization of dermatology products, has...
Medical Marketing and Media - Centron
July 1, 2008 -- Organic growth continued to fuel revenue for this relatively new shop When considering Centron, the word "supernova" comes to mind-and it isn't...
Chain Drug Review - After win in court, Perrigo rolls out clobetasol propionate
April 28, 2008 -- ALLEGAN, Mich. -- Perrigo Co. has launched clobetasol propionate foam. The company took the action after a United States District Court in New Jersey...
Internal Medicine News - Dermatoses foam approved
April 1, 2007 -- Olux-E (clobetasol propionate, 0.05%) foam, is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive...
